Cargando…
Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
Benign prostatic hyperplasia (BPH) represents a pattern of non-malignant growth of prostatic fibromuscular stroma. Metabolic disturbances such us pre-diabetes and metabolic syndrome may have a role in BPH pathophysiology. A potential explanation for the above relationship involves the insulin-like g...
Autores principales: | Protopsaltis, Ioannis, Ploumidis, Achilles, Sergentanis, Theodoros N., Constantoulakis, Padelis, Tzirogiannis, Kostantinos, Kyprianidou, Chrysoula, Papazafiropoulou, Athanasia K., Melidonis, Andreas, Delakas, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868595/ https://www.ncbi.nlm.nih.gov/pubmed/24367483 http://dx.doi.org/10.1371/journal.pone.0081411 |
Ejemplares similares
-
Benign Prostatic Hyperplasia
Publicado: (2015) -
Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015) -
Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010) -
Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009) -
Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)